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SUMMARY
This paper is aimed at investigating whether peripheral dysfunction at the neuromuscular level may represent 
a pain generator in fibromyalgia.
We studied the prevalence of spasmophilia (SP), carpal tunnel syndrome (CTS) and ulnar neuropathy at the 
elbow (UNE) in a group of 40 subjects suffering from fibromyalgia. Clinical and electrophysiological data were 
obtained to ascertain whether comorbid conditions were present. For subjective evaluation of symptoms sever-
ity, validated questionnaires for CTS and UNE were completed by patients. Twenty subjects were positive for 
SP (50%); CTS was diagnosed in 12 subjects (30%); no patient suffered from UNE; 6 subjects were affected at 
the same time by SP and CTS (15%); 14 subjects (35%) were affected by SP alone. The prevalence of CTS and 
SP was higher in fibromyalgia subjects than in the general population. The scores of the questionnaires related 
to CTS were significantly higher in fibromyalgia subjects positive for CTS, with respect to the other subjects.
In fibromyalgia, CTS and SP may be considered clinical entities in themselves, the importance of which lies in 
their acting as peripheral pain generators that enhance or initiate central sensitization, thereby contributing to 
chronic widespread pain. The amplification of pain is indeed a correctable/misguided message that occurs in-
side the brain of fibromyalgia subjects and identification and local treatment of pain generators would lessen the 
total pain burden. The magnitude of the overlap in symptoms between fibromyalgia and CTS/SP necessitates 
careful investigation of these conditions.
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n	 INTRODUCTION
Subjects developing fibromyalgia com-monly have a lifelong history of 
chronic pain throughout their body with 
concomitant depression and sleep disorder; 
they are likely to have a history of head-
aches, dysmenorrhea, temporomandibular 
joint disorder, functional gastrointestinal 
and urinary disorders, endometriosis, and 
other regional pain syndromes (1). The 
etiology of fibromyalgia is still unclear. 
Several factors such as dysfunction of the 
central and autonomic nervous systems, 
neurotransmitters, hormones, immune sys-
tem, external stressors, psychiatric aspects, 
and others seem to be involved. 
Although central sensitization is consid-
ered to be the main mechanism involved, 
a contribution by peripheral pain genera-
tors to the syndrome is, however, being 
increasingly recognized (1, 2). In effect, fi-
bromyalgia patients present a significantly 
higher frequency of numerous painful fo-
cal disorders with respect to healthy sub-
jects (3). The relationship of the comorbid 
conditions to fibromyalgia has not been 
clarified. They can be considered as the 
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result of hyper-effective ascending central 
pain transmission resulting from deficient 
descending pain inhibition, or they can 
be considered as clinical entities in them-
selves, whose importance in fibromyalgia 
lies in their acting as peripheral pain gen-
erators that enhance or initiate central sen-
sitization. 
The present paper is aimed at investigat-
ing whether peripheral dysfunction at the 
neuromuscular level may represent a pain 
generator in fibromyalgia. We studied the 
prevalence of neuromuscular hyperexcit-
ability syndrome (spasmophilia), carpal 
tunnel syndrome (CTS) and ulnar neuropa-
thy at the elbow (UNE) comorbidity in 40 
fibromyalgia patients. Some of the wide 
range of symptoms of fibromyalgia, such 
as pain and paresthesia, are indeed com-
mon in compressive peripheral neuropa-
thies and spasmophilia (SP), so one disease 
may mask the other. 
n	 MATERIALS AND METHODS
Subjects
A prospective study was carried out on 40 
patients (mean age 47.9±12) who were re-
ferred to the Rheumatology Unit of Siena 
from January to December 2012 with a 
diagnosis of fibromyalgia according to the 
1990 and 2010 American College Rheuma-
tology criteria. All patients were female. 
We excluded all subjects who had under-
gone surgery of the upper limb, as well as 
those with radiculopathy and plexopathy 
of the arm, polyneuropathy, previous arm 
trauma, diabetes, rheumatic or thyroid dis-
eases, renal failure, history of alcoholism 
and central nervous system diseases, ma-
lignancy in the previous 5 years, and/or 
previous intake of medication considered 
toxic to the peripheral nervous system. All 
40 fibromyalgia patients underwent clinical 
examination and electrophysiological stud-
ies to ascertain whether comorbid condi-
tions, specifically CTS, UNE and SP, were 
present in these subjects. One investigator 
carried out neurophysiological studies.
Finally, we enrolled a control group of 40 
healthy volunteers matched for sex and age 
with the fibromyalgia population, to ex-
plore the prevalence of the SP in a healthy 
population. The latter data is indeed almost 
entirely lacking in available literature. 
There is only one paper from 1986, which 
reported an SP prevalence of 17% in the 
healthy population (4). 
Diagnostic criteria for carpal tunnel 
syndrome
Carpal tunnel syndrome was diagnosed 
according to the American Academy of 
Neurology criteria (5), which include clini-
cal history, symptoms and neurographic 
evidence of slowing of distal median nerve 
conduction velocity. Clinical history and 
symptoms included any kind of paresthe-
sia and/or pain in all or part of the hand 
innervated by the median nerve. The elec-
trophysiological examinations were con-
ducted on 80 hands belonging to all 40 
fibromyalgia subjects. Surface recording 
electrodes were placed over the motor 
point of the abductor pollicis brevis (APB) 
muscle; distal motor latency (DML) was 
measured with a distance of 7 cm between 
the stimulation point of the nerves at the 
wrist and the APB muscles. A rubber-suc-
tion surface recording electrode placed on 
the wrist and stimulating ring electrodes 
placed on the fingers were used for medi-
an sensory conduction studies. Maximum 
orthodromic sensory conduction velocity 
(SCV) was calculated from the onset of 
the negative peak, and the responses were 
averaged. Maximum sensory nerve action 
potential amplitude (SNAPa) of the median 
(M3, middle finger-wrist; M4, ring finger-
wrist) nerve was determined.
The minimum electrophysiological criteria 
to confirm the clinical diagnosis of CTS 
were prolonged DML (≥4.4 ms) and/or ab-
normal SCV of the median nerve (≤45.2 m/s 
for M3 and ≤43 m/s for M4). When absolute 
values of SCV were normal in the digit-wrist 
segment, a difference of 10 m/s between 
SCVs of ulnar nerve (U4, ring finger-wrist) 
and M4 was considered significant.
Diagnostic criteria for ulnar neuropathy 
at the elbow
The electrophysiological examinations were 
conducted on 80 hands belonging to all 40 
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fibromyalgia subjects. Surface recording 
electrodes were placed over the motor point 
of the abductor digiti minimi (ADM) mus-
cle; motor conduction velocity (MCV) was 
calculated from below the elbow to the wrist 
and below the elbow to above the elbow 
(10 cm across-elbow distances); DML was 
measured with a distance of 7 cm between 
the stimulation point of the nerve at the wrist 
and the ADM; compound muscle action po-
tential amplitude (CMAPa) was also meas-
ured from baseline to the negative peak. A 
rubber-suction surface recording electrode 
placed on the wrist and stimulating ring 
electrodes placed on the fingers were used 
for sensory conduction studies. Maximum 
SCV was calculated from the onset of the 
negative peak, and the responses were aver-
aged. Maximum SNAPa of the U4 and U5 
(little finger-wrist) was determined. Needle 
electromyography of ADM and first dorsal 
interosseous muscles was performed.
Diagnosis of UNE was based on the coex-
istence of:
1) clinical history and symptoms suggest-
ing UNE: numbness and paraesthesia or 
pain in the part of the hand innervated 
by the ulnar nerve; pain at the elbow; 
motor symptoms might be absent or 
ranged from mild clumsiness to severe 
weakness of the hand;
2) electrophysiological criteria: reduction 
of MCV from above elbow to below 
elbow (MCV less than 50 m/s); MCV 
from above to below elbow more than 
10 m/s slower than MCV from below 
elbow to wrist; decrease in CMAPa 
greater than 20% between stimulation 
above and below elbow; reduction of 
ulnar nerve SNAPa from U5; abnormal 
electromyography of ulnar hand mus-
cles. These methods were in accordance 
with the guidelines of the American 
Academy of Electrodiagnostic Medi-
cine (6).
Diagnostic criteria for spasmophilia
Spasmophilia diagnosis was based on elec-
tromyographic criteria. A concentric nee-
dle electrode was placed on the first dor-
sal interosseous muscle of one hand, then 
using a sphygmomanometer cuff, a pres-
sure greater than 20 mmHg of the patient’s 
systolic blood pressure was applied to the 
arm and maintained for 8 minutes. Elec-
tromyographic spontaneous activity was 
recorded during this time, for 5 minutes 
after decompression of the cuff and then 
during hyperpnea for 3 minutes. Diagno-
sis of SP was considered in the presence 
of spontaneous doublets, triplets and mul-
tiplets either during/after ischemia or dur-
ing/after hyperpnea. The same investigator 
carried out neurophysiological studies both 
on fibromyalgia subjects and on the control 
population.
Self-evaluation of symptoms and 
functional status of hand questionnaires
For subjective evaluation of severity of 
symptoms, the Italian version of the Bos-
ton Questionnaire (BQ) (7) and UNE 
Questionnaire (UNEQ) (8) were complet-
ed by the 40 fibromyalgia patients. The 
BQ and UNEQ were validated to meas-
ure subjective discomfort experienced by 
CTS and UNE patients, respectively. The 
BQ is divided into two parts. The first part 
(11 items) evaluates symptoms (BQS), 
and the second part (8 items) evaluates 
the functional status of the hand (BQM). 
The UNEQ is composed of nine questions 
and it considers symptoms (numbness and 
tingling) of the fourth and fifth fingers, 
possible elbow pain and changes in these 
symptoms in relation to elbow position. 
Hand weakness is also evaluated. Each 
question of UNEQ and BQ has five possi-
ble answers scored from 1 to 5, according 
to severity of symptoms or the difficulty of 
performing a certain activity. Each score 
is calculated as the mean of the score of 
the individual items. Severe impairment is 
indicated by a high score.
Statistical analysis
Data was tested for normality (Kolmogo-
rov-Smirnov distance method). Values in 
the groups were compared using one-way 
analysis of variance (ANOVA). If compari-
son of groups showed significant differ-
ences, Bonferroni’s multiple comparison 
test was performed. Statistical significance 
was assumed if the p value was <0.05. Sta-
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tistical difference in the frequency of SP 
between fibromyalgia patients and controls 
were calculated with Fisher’s exact test. 
Results are presented as mean values and 
standard deviation (SD).
n	 RESULTS
All 40 fibromyalgia patients were exam-
ined. Carpal tunnel syndrome was diag-
nosed in 12 subjects (30%). No patient 
was suffering from UNE. Twenty subjects 
resulted positive for SP (50%), while the 
prevalence of SP in the control group was 
10% (4 out 40 subjects). Six patients were 
affected at the same time by SP and CTS 
(15%); 14 (35%) were affected by SP 
alone. Carpal tunnel syndrome severity 
was similar between the latter and the for-
mer group. 
Table I shows demographic data and results 
of questionnaires administered to patients. 
There are no significant differences be-
tween groups for UNEQ. Conversely, BQ 
scores were higher in subjects with CTS 
comorbidity. In particular, both BQS and 
BQM scores were significantly higher in fi-
bromyalgia subjects affected by CTS, with 
respect to all the other subjects (that is, the 
fibromyalgia subjects without comorbidity 
and/or positive for SP alone). 
The prevalence of SP in the healthy popu-
lation was 10% (4 out 40 subjects). There 
was a significant difference in the frequen-
cy of SP between fibromyalgia patients and 
controls (p<0.0002).
n	 DISCUSSION
The mechanism of sensory symptoms in fi-
bromyalgia has not been exactly elucidated 
and it is mainly considered to be a result 
of abnormal sensory perception. In effect, 
a recent review stated that fibromyalgia 
could be thought of as a centralized pain 
state; centralized refers to pain originat-
ing in or amplified by the central nervous 
system (1). This belief does not imply that 
peripheral nociceptive/neuropathic input 
is not contributing to pain in fibromyalgia 
subjects. 
Some of the wide range of symptoms of 
fibromyalgia, such as pain and paraesthe-
sia are common in compressive peripheral 
neuropathies and SP so that one disease 
may mask the other. In the present paper 
we have studied the prevalence of three 
common pathological conditions that cause 
paraesthesia and/or pain, namely CTS, 
UNE and SP, in 40 fibromyalgia patients. 
The results demonstrate a high prevalence 
of SP (50%) and CTS (30%); conversely, 
no patient was affected by UNE. 
The prevalence of CTS is significantly 
higher in fibromyalgia subjects than in 
the general population (2.7%) (9). The 
Table I - Demographic data, questionnaires results and differences between the groups.
Total FM
no. 40
Negative
(no. 15)
CTS tot
(no. 12)
SP tot
(no. 20)
CTS+SP
(no. 6)
SP alone
(no. 14) p values
Bonferroni’s Multiple
Comparison Test
Age (years) 46.6±11.3 51.8±11.7 50.8±11 50.82±10 46.1±15 n.s.
BQS 2.54±0.68 3.5±0.65 2.99±0.83 3.67±0.57 2.59±0.7 p=0.001
Negative vs CTS tot*
Negative vs CTS+SP*
SP only vs CTS tot*
BQM 2.21±0.64 3.4±0.8 2.86±1.07 3.68±0.7 2.46±0.95 p=0.003
Negative vs CTS tot*
Negative vs CTS+SP*
SP only vs CTS tot*
UNEQ 2.1±0.75 2.85±0.9 2.45±0.9 3.1±0.85 2.06±0.7.5 n.s.
BQF: Boston questionnaire functional; BQS: Boston questionnaire symptoms; CTS: carpal tunnel syndrome; CTS total: FM subjects 
with CTS comorbidity; CTS+SP: FM subjects positive for both CTS and SP; FM: fibromyalgia; Negative: FM subjects without comor-
bidities; no: number; n.s.: not significant; SP: spasmophilia; SP alone: FM subjects with SP comorbidity alone; SP total: FM subjects 
positive for SP alone and/or SP and CTS; Total FM: all fibromyalgia subjects, irrespective of the comorbidities; UNEQ: questionnaire 
ulnar neuropathy elbow. 
Results are reported as mean values±standard deviation. Multiple comparison test: *0.05 (the results of the post hoc Bonferroni test 
are reported only when significant).
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BQ scores were abnormal only in CTS 
subjects whereas there are no significant 
differences between groups for UNEQ. 
The self-administered questionnaires BQ 
and UNEQ are a way to assess patient 
discomfort and represent a reliable and 
reproducible instrument to evaluate CTS 
and UNE symptoms, respectively (7, 8). 
The strong association between CTS and 
a high BQ score in fibromyalgia patients 
emphasizes the fact that CTS is a crucial 
cause of impairment in these patients. 
This means that sensory symptoms re-
ported by fibromyalgia subjects were, at 
least in part, related to a specific periph-
eral pain generator. In reality, many pa-
pers report that the prevalence of CTS in 
fibromyalgia is higher than in the general 
population (10-14). Conversely, data on 
UNE prevalence in fibromyalgia are very 
rare. Only one paper analyzed peripheral 
nerve conduction in 33 fibromyalgia sub-
jects and none had ulnar nerve conduc-
tion failure (13). The high prevalence of 
CTS in the fibromyalgia population sug-
gests that common underlying mecha-
nisms are at work. At present, there is no 
study explaining the mechanisms why 
CTS is frequently observed in patients 
with fibromyalgia. 
Regarding SP, in contrast to CTS, epide-
miologic data concerning the general pop-
ulation are very rare. 
In the available literature only one pa-
per has explored the prevalence of SP 
in healthy individuals, reporting a 17% 
prevalence (4), while in the present paper 
we report a prevalence of 10%. Both per-
centages are lower than that reported in 
fibromyalgia populations by Bazzichi et 
al. (15) (25.8% of cases) and by us (50% 
of cases), suggesting a comorbidity be-
tween fibromyalgia and SP. The basis of 
neuromuscular hyperexcitability in SP is 
thought to be a disturbance of calcium 
and magnesium metabolism. From the 
study by Bazzichi et al., (15) significant 
differences emerge between the patients 
affected by fibromyalgia alone and the 
fibromyalgia group positive for SP: the 
latter group had lower levels of intracel-
lular magnesium compared to fibromyal-
gia patients negative for SP, suggesting a 
relationship between SP and dysfunction 
at the neuromuscular level.
n	 CONCLUSIONS
In conclusion, some neuromuscular dis-
eases, such CTS and SP, are associated 
conditions in fibromyalgia subjects, rep-
resenting peripheral pain generators in 
fibromyalgia. In reality, although fibromy-
algia is generally not thought to be caused 
by peripheral damage or inflammation, 
some evidence exists supporting treatment 
of peripheral pain generators as considered 
factors driving central sensitization (1). 
The amplification of pain is indeed a cor-
rectable/misguided message that occurs 
inside the brain of fibromyalgia subjects 
and the identification and the local treat-
ment of pain generators lessens the total 
pain burden and facilitates rehabilitation 
(3, 16). This is particularly important for 
a syndrome like fibromyalgia where man-
agement options available so far are still of 
limited effectiveness in a large percentage 
of cases (17). 
The key message of our report is that the 
magnitude of the association between fibro-
myalgia and CTS/SP requires a thoughtful 
search for these pain generators since their 
presence may be masked by the symptoms 
of fibromyalgia. 
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